An FDA-regulated clinical trial launched earlier this year at Yale-New Haven Hospital means that for the first time in the U.S., tissue-engineered blood vessels are being implanted in humans. The implants are made from a synthetic scaffold seeded with stem cells from the patient’s own bone marrow. The implants are used to connect a major cardiac vein to the artery...